First Report Customer Care 
All time: 4.6

Latest / Last 30 Days: 5.0

527 Reviews

Credit Rating - DAUBLIN BIOTECHNOLOGY (UK) CO., LTD

ANALYSIS
Credit Risk Update: ACCOUNTS DUE FLAG: DAUBLIN BIOTECHNOLOGY (UK) CO., LTD, 14 WELLS VIEW DRIVE, LONDON, BR2 9UL. The legal status is a Private Limited Company and the current status at the registry of companies is Active - Proposal to Strike off. The last filed accounts are dated 30 September 2020. The company was incorporated on 29 September 2015.

The accounts next due date is 30 June 2022. There are no mortgages.

The above was based on public record information as at 5 November 2024 and may not reflect the current status. Please access the current report to ascertain the current status and credit rating.
SUMMARY
Registered Number: 09799229
Date Incorporated: 29 September 2015
Date Latest Accounts: 30 September 2020
BUSINESS INFORMATION
Legal Form: Private Limited Company
Previous Names: None
Registered Number: 09799229
Annual Return: Unknown
Registered Office: 14 WELLS VIEW DRIVE, LONDON, BR2 9UL
SIC Code and Operations: 99999
SECURED CREDITORS
Number of Mortgages 0
Satisfied Mortgages 0
Part Satisfied Mortgages 0
Unsatisfied Mortgages 0
CREDIT RISK RATING
This is the credit risk assessment used by one of the top UK credit reference agencies.
Risk Score (1-100):

DAUBLIN BIOTECHNOLOGY (UK) CO., LTD

Click Here

to view this information

Risk Assessment:
Credit Rating:



First Report Score: (0-10):

Financial Status Guide:
10  trafficlight Very Strong
9   Strong
8 Very Good
7 Good
6 Above Average
5 Average
4 Below Average
3 Poor
2 Weak
1 Very Weak
0 Critical
Report Created On 15 November 2024 Copyright © 2024 First Report Ltd


Recent Searches

Reg No. Reg Name Status
09374695 DAUBNEY (HOLDINGS) LIMITED Active
07847773 DAUBNEY BUSINESS SERVICES LIMITED Active
03144918 DAUBNEY COMMERCIAL PROPERTIES LIMITED Active
10270712 DAUBNEY ELECTRICAL LIMITED Active
14192453 DAUBNEY FIRE AND SECURITY LTD Active - Proposal to Strike off

In using this service you agree to the Terms and Conditions

© 2024 First Report Ltd